Thompson Rahsaan insider trades
Thompson Rahsaan has filed 12 Form 4s with the SEC that we hold, for Zevra Therapeutics, INC. (ZVRA) (Chief Legal & Compliance), GRTS (EVP and General Counsel) and Lyell Immunopharma, Inc. (LYEL) (Chief Legal Officer). Across all of them we count 0 purchases worth $0 and 5 sales worth $1.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 4 sales ($969.3K). The largest single trade was a sale of 42,666 shares of Zevra Therapeutics, INC. worth $474.8K, dated 2026-08-14. The first filing on our record is dated 2021-11-19 and the latest 2026-08-17.
Zevra Therapeutics, INC. (ZVRA)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2025-06-26 | S, sale reported on Form 4 | 24,000 | $221.0K | 2025-06-30 | SEC |
| 2026-01-30 | S, sale reported on Form 4 | 4,080 | $36.0K | 2026-02-02 | SEC |
| 2026-05-11 | S, sale reported on Form 4 | 1,794 | $20.3K | 2026-05-13 | SEC |
| 2026-06-22 | S, sale reported on Form 4 | 34,557 | $438.2K | 2026-06-23 | SEC |
| 2026-08-14 | S, sale reported on Form 4 | 42,666 | $474.8K | 2026-08-17 | SEC |
GRTS
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Lyell Immunopharma, Inc. (LYEL)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1788524) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
